2019 Interactive Breakout Discussions
Tuesday, February 19
BREAKOUT DISCUSSION GROUPS
4:10 Find Your Table and Meet Your Moderator
4:15 Interactive Breakout Discussion Groups
Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become
an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and,
most importantly, participate in active idea sharing.
5:00 Welcome Reception in the Exhibit Hall
6:30 Close of Day
We are currently building the agendas for SCOPE 2019 and the topics and co-moderators for the breakout discussion groups will be posted later. Below are some examples from the 2018 program.
TABLE 1: What Is Holding Back the Adoption of eConsent?
TABLE 2: Embracing Best Practices in Protocol Design to Reduce Protocol Amendments and Improve Trials
TABLE 3: Coordinating Contracting and Payments to Enhance Efficiencies
TABLE 4: Barriers and Opportunities in Site Adoption of Clinical Trial Technology
TABLE 5: Strategies for Accelerating Recruitment in Complex Clinical Trials in a Resource Constrained Environment
TABLE 6: Precision Feasibility in Precision Medicine-Driven Trials
TABLE 7: Optimizing Country and Site Selection: Strategies for Positioning Trials for Success Using a Global Footprint
TABLE 8: Improving Both Time and Quality in Site Activation and Study Start-Up
TABLE 9: Strategies for Patient-Centric Trial Design and Digital Patient Engagement
TABLE 10: Balancing Budgets and Performance in Resource Management and Capacity Planning
TABLE 11: RBM in a Finance and Resource Limited Environment
TABLE 12: Vendor Performance Metrics and KPIs
TABLE 13: Understanding and Implementing the New Reality of Diversity in Clinical Trials
TABLE 14: Selecting, Developing and Incorporating Novel Endpoints, Generated from Data Captured by Mobile Technologies, for Use in Clinical Trials
TABLE 15: RWE in Clinical Trial Research and Patient Recruitment
TABLE 16: Visual Analytics in Clinical Research
TABLE 17: Addressing Chronic Site and CRA Turnover Issues through a Competency-Based Approach to Workforce Development
TABLE 18: Biospecimen, Central Lab and Technology
TABLE 19: Artificial Intelligence and Machine Learning: Extreme Case of Data Analytics?
TABLE 20: Blurring the Division between Clinical and Observational Studies
TABLE 21: Driving Fully eSource Clinical Trial